Persistence, Adherence and Clinical Effectiveness in Patients With Chronic Hepatitis B Viral Infection Treated With Entecavir in Real Life
Phase of Trial: Phase IV
Latest Information Update: 17 Apr 2016
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 17 Apr 2016 Two year results (n=216) presented at The International Liver Congress™ 2016.
- 24 Jun 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 14 Aug 2014 Planned End Date changed from 1 Apr 2014 to 1 Dec 2014, according to the ClinicalTrials.gov record.